Literature DB >> 22422617

Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.

Hesham M El-Shewy1, Mimi Sohn, Parker Wilson, Mi Hye Lee, Samar M Hammad, Louis M Luttrell, Ayad A Jaffa.   

Abstract

The pro-fibrotic connective tissue growth factor (CTGF) has been linked to the development and progression of diabetic vascular and renal disease. We recently reported that low-density lipoproteins (LDL) induced expression of CTGF in aortic endothelial cells. However, the molecular mechanisms are not fully defined. Here, we have studied the mechanism by which LDL regulates CTGF expression in renal mesangial cells. In these cells, treatment with pertussis toxin abolished LDL-stimulated activation of ERK1/2 and c-Jun N-terminal kinase (JNK), indicating the involvement of heterotrimeric G proteins in LDL signaling. Treatment with LDL promoted activation and translocation of endogenous sphingosine kinase 1 (SK1) from the cytosol to the plasma membrane concomitant with production of sphingosine-1-phosphate (S1P). Pretreating cells with SK inhibitor, dimethylsphinogsine or down-regulation of SK1 and SK2 revealed that LDL-dependent activation of ERK1/2 and JNK is mediated by SK1. Using a green fluorescent protein-tagged S1P₁ receptor as a biological sensor for the generation of physiologically relevant S1P levels, we found that LDL induced S1P receptor activation. Pretreating cells with S1P₁/S1P₃ receptor antagonist VPC23019 significantly inhibited activation of ERK1/2 and JNK by LDL, suggesting that LDL elicits G protein-dependent activation of ERK1/2 and JNK by stimulating SK1-dependent transactivation of S1P receptors. Furthermore, S1P stimulation induced expression of CTGF in a dose-dependent manner that was markedly inhibited by blocking the ERK1/2 and JNK signaling pathways. LDL-induced CTGF expression was pertussis toxin sensitive and inhibited by dimethylsphinogsine down-regulation of SK1 and VPC23019 treatment. Our data suggest that SK1-dependent S1P receptor transactivation is upstream of ERK1/2 and JNK and that all three steps are required for LDL-regulated expression of CTGF in mesangial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422617      PMCID: PMC3355554          DOI: 10.1210/me.2011-1261

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  62 in total

Review 1.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 2.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions.

Authors:  N Murata; K Sato; J Kon; H Tomura; M Yanagita; A Kuwabara; M Ui; F Okajima
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 4.  Sphingosine-1-phosphate: signaling inside and out.

Authors:  S Spiegel; S Milstien
Journal:  FEBS Lett       Date:  2000-06-30       Impact factor: 4.124

5.  Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.

Authors:  Bruce L Riser; Mark Denichilo; Pedro Cortes; Cathryn Baker; Janet M Grondin; Jerry Yee; Robert G Narins
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

6.  Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus.

Authors:  S M Twigg; M M Chen; A H Joly; S D Chakrapani; J Tsubaki; H S Kim; Y Oh; R G Rosenfeld
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

7.  In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury.

Authors:  I E Blom; A J van Dijk; L Wieten; K Duran; Y Ito; L Kleij; M deNichilo; T J Rabelink; J J Weening; J Aten; R Goldschmeding
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

8.  Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells.

Authors:  A J Jenkins; V Velarde; R L Klein; K C Joyce; K D Phillips; R K Mayfield; T J Lyons; A A Jaffa
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

Review 9.  Connective tissue growth factor: what's in a name?

Authors:  E E Moussad; D R Brigstock
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

10.  Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.

Authors:  Y Yatomi; T Ohmori; G Rile; F Kazama; H Okamoto; T Sano; K Satoh; S Kume; G Tigyi; Y Igarashi; Y Ozaki
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

View more
  7 in total

1.  Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability.

Authors:  Yang Yu; Shoudong Guo; Yumei Feng; Lei Feng; Yingjie Cui; Guohua Song; Tian Luo; Ke Zhang; Yiwei Wang; Xian-Cheng Jiang; Shucun Qin
Journal:  Lipids       Date:  2013-10-25       Impact factor: 1.880

2.  Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort.

Authors:  Kelly J Hunt; Miran A Jaffa; Sara M Garrett; Deirdre K Luttrell; Kenneth E Lipson; Maria F Lopes-Virella; Louis M Luttrell; Ayad A Jaffa
Journal:  Diabetes Care       Date:  2018-01-30       Impact factor: 19.112

3.  Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: Gene expression profiles in the kidneys.

Authors:  Yuko Watanabe; Momoko Yoshida; Kyosuke Yamanishi; Hideyuki Yamamoto; Daisuke Okuzaki; Hiroshi Nojima; Teruo Yasunaga; Haruki Okamura; Hisato Matsunaga; Hiromichi Yamanishi
Journal:  Int J Mol Med       Date:  2015-07-10       Impact factor: 4.101

4.  Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover.

Authors:  Nikki L Raftopulos; Tinashe C Washaya; Andreas Niederprüm; Antonia Egert; Mariam F Hakeem-Sanni; Bianca Varney; Atqiya Aishah; Mariya L Georgieva; Ellinor Olsson; Diandra Z Dos Santos; Zeyad D Nassar; Blake J Cochran; Shilpa R Nagarajan; Meghna S Kakani; Jordan F Hastings; David R Croucher; Kerry-Anne Rye; Lisa M Butler; Thomas Grewal; Andrew J Hoy
Journal:  Cancer Metab       Date:  2022-01-15

Review 5.  A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.

Authors:  Norishi Ueda
Journal:  Int J Mol Sci       Date:  2022-04-04       Impact factor: 5.923

Review 6.  Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate.

Authors:  Norishi Ueda
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

7.  Electronegative low density lipoprotein induces renal apoptosis and fibrosis: STRA6 signaling involved.

Authors:  Chao-Hung Chen; Liang-Yin Ke; Hua-Chen Chan; An-Sheng Lee; Kun-Der Lin; Chih-Sheng Chu; Mei-Yueh Lee; Pi-Jung Hsiao; Chin Hsu; Chu-Huang Chen; Shyi-Jang Shin
Journal:  J Lipid Res       Date:  2016-06-02       Impact factor: 5.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.